We strive to offer our consumers and clients high value-added products derived from cannabis plants, helping patients in Colombia and around the world to achieve enhanced wellbeing. We actively promote shared benefits for all stakeholders along the value chain by abiding to fair business models founded on trust, strictly within the boundaries of the law.
In April 2018, Clever Leaves became the first Colombian company to be fully-licensed in medical cannabis cultivation and extraction; as well as receiving production quotas on both harvest and extraction. It is also recognized as the first Colombian operator to receive the permit to export product from Colombia as well as to import product into Canada.
With this, the company is executing on its mission: Bring pharmaceutical-grade medicinal cannabis solutions for patients globally.
Clever Leaves was founded in 2016 with the vision of forging a strong operating team based on low-cost, high quality medical products which could shape the industry for Colombia and eventually the world.
The vision depending on careful and detailed strategic planning on various fronts. By the end of 2018, Clever Leaves was operating 5 hectares of cultivation as well as one of Latin America’s first GMP-compliant extraction facilities. With the goal of operating on over 100 hectares by 2023, Clever Leaves is in the process of a significant expansion. With approximately 200 employees, Clever Leaves is one of the fastest-growing and largest operators in Colombia.
M.Sc. Biochemist. 10+ yrs. pharmaceutical R&D and product specialists.
Head Quality Control
16+ yrs. in pharmaceutical quality control and laboratories. Experience in GMP Certifiaction
Advisory Team Lead Geneticist
Cannabis Specialist. Master Grower. 30+ yrs. cannabis industry